title: Matching procedure to morphology improves outcomes in neonates with tricuspid atresia.
abstract: OBJECTIVE
  This study was undertaken to characterize morphologic substrate of tricuspid atresia with ventriculoarterial concordance and discriminate management strategies that lead to successful definitive repair.
  
  
  METHODS
  From 1999 to 2004, a total of 150 babies with type I tricuspid atresia were enrolled from first diagnosis at 26 institutions. Antegrade pulmonary blood flow was absent in 19%, restricted in 54%, and unrestricted in 28%. Competing-risk methodology determined the time-related prevalence and risk factors for death versus cavopulmonary anastomosis and subsequent death versus Fontan completion.
  
  
  RESULTS
  Overall 5-year survival was 86%. Initial palliation included systemic-pulmonary arterial shunt in 64%, pulmonary artery banding in 11%, and cavopulmonary anastomosis in 24%. Median age at cavopulmonary anastomosis was 6 months, with 83% undergoing bidirectional Glenn shunt and 17% undergoing hemi-Fontan procedure. By the age of 2 years, 89% had cavopulmonary anastomosis, 6% were dead, and 4% remained alive without cavopulmonary anastomosis. Risk factors for death without cavopulmonary anastomosis included presence of mitral regurgitation (P = .03) and palliation with systemic-pulmonary arterial shunts not originating from the innominate artery (P = .04). Factors associated with decreased transition rate to cavopulmonary connection included patient variables (younger admission age to a participating institution, noncardiac anomalies) and procedural variables (larger systemic-pulmonary arterial shunt diameter, previous palliation). Of patients undergoing cavopulmonary anastomosis, 75% had undergone a Fontan operation within 3 years.
  
  
  CONCLUSIONS
  Smaller shunt size and decreased pulmonary blood flow decrease mortality after initial palliation and increase the rate of successful transition to cavopulmonary anastomosis. Outcomes can be improved by placing smaller shunts from the innominate artery, especially in patients with any mitral regurgitation.
authors.affiliation: Division of Cardiology and Cardiovascular Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Tara
authors.initials: T
authors.lastname: Karamlou
authors.forename: David A
authors.initials: DA
authors.lastname: Ashburn
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Caldarone
authors.forename: Eugene H
authors.initials: EH
authors.lastname: Blackstone
authors.forename: Richard A
authors.initials: RA
authors.lastname: Jonas
authors.forename: Marshall L
authors.initials: ML
authors.lastname: Jacobs
authors.forename: William G
authors.initials: WG
authors.lastname: Williams
authors.forename: Ross M
authors.initials: RM
authors.lastname: Ungerleider
authors.forename: Brian W
authors.initials: BW
authors.lastname: McCrindle
mesh_terms: D006348:Cardiac Surgical Procedures / Q000379:methods; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011446:Prospective Studies; D012307:Risk Factors; D018785:Tricuspid Atresia / Q000145:classification / Q000401:mortality / Q000473:pathology* / Q000601:surgery*